Literature DB >> 12006649

Utrophin binds laterally along actin filaments and can couple costameric actin with sarcolemma when overexpressed in dystrophin-deficient muscle.

Inna N Rybakova1, Jitandrakumar R Patel, Kay E Davies, Peter D Yurchenco, James M Ervasti.   

Abstract

Dystrophin is widely thought to mechanically link the cortical cytoskeleton with the muscle sarcolemma. Although the dystrophin homolog utrophin can functionally compensate for dystrophin in mice, recent studies question whether utrophin can bind laterally along actin filaments and anchor filaments to the sarcolemma. Herein, we have expressed full-length recombinant utrophin and show that the purified protein is fully soluble with a native molecular weight and molecular dimensions indicative of monomers. We demonstrate that like dystrophin, utrophin can form an extensive lateral association with actin filaments and protect actin filaments from depolymerization in vitro. However, utrophin binds laterally along actin filaments through contribution of acidic spectrin-like repeats rather than the cluster of basic repeats used by dystrophin. We also show that the defective linkage between costameric actin filaments and the sarcolemma in dystrophin-deficient mdx muscle is rescued by overexpression of utrophin. Our results demonstrate that utrophin and dystrophin are functionally interchangeable actin binding proteins, but that the molecular epitopes important for filament binding differ between the two proteins. More generally, our results raise the possibility that spectrin-like repeats may enable some members of the plakin family of cytolinkers to laterally bind and stabilize actin filaments.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12006649      PMCID: PMC111123          DOI: 10.1091/mbc.01-09-0446

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  54 in total

1.  WW and EF hand domains of dystrophin-family proteins mediate dystroglycan binding.

Authors:  W Chung; J T Campanelli
Journal:  Mol Cell Biol Res Commun       Date:  1999 Sep-Dec

2.  Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan.

Authors:  X Huang; F Poy; R Zhang; A Joachimiak; M Sudol; M J Eck
Journal:  Nat Struct Biol       Date:  2000-08

3.  Utrophin lacks the rod domain actin binding activity of dystrophin.

Authors:  K J Amann; A W Guo; J M Ervasti
Journal:  J Biol Chem       Date:  1999-12-10       Impact factor: 5.157

4.  Biochemical characterisation of the actin-binding properties of utrophin.

Authors:  C A Moores; J Kendrick-Jones
Journal:  Cell Motil Cytoskeleton       Date:  2000-06

Review 5.  Developments in gene therapy for muscular dystrophy.

Authors:  D Hartigan-O'Connor; J S Chamberlain
Journal:  Microsc Res Tech       Date:  2000 Feb 1-15       Impact factor: 2.769

6.  Identification and characterisation of transcript and protein of a new short N-terminal utrophin isoform.

Authors:  R A Zuellig; B C Bornhauser; I Knuesel; F Heller; J M Fritschy; M C Schaub
Journal:  J Cell Biochem       Date:  2000-04       Impact factor: 4.429

7.  The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin.

Authors:  I N Rybakova; J R Patel; J M Ervasti
Journal:  J Cell Biol       Date:  2000-09-04       Impact factor: 10.539

8.  An epidermal plakin that integrates actin and microtubule networks at cellular junctions.

Authors:  I Karakesisoglou; Y Yang; E Fuchs
Journal:  J Cell Biol       Date:  2000-04-03       Impact factor: 10.539

9.  Extensive but coordinated reorganization of the membrane skeleton in myofibers of dystrophic (mdx) mice.

Authors:  M W Williams; R J Bloch
Journal:  J Cell Biol       Date:  1999-03-22       Impact factor: 10.539

10.  Adhesion-dependent tyrosine phosphorylation of (beta)-dystroglycan regulates its interaction with utrophin.

Authors:  M James; A Nuttall; J L Ilsley; K Ottersbach; J M Tinsley; M Sudol; S J Winder
Journal:  J Cell Sci       Date:  2000-05       Impact factor: 5.285

View more
  46 in total

1.  Disease-causing missense mutations in actin binding domain 1 of dystrophin induce thermodynamic instability and protein aggregation.

Authors:  Davin M Henderson; Ann Lee; James M Ervasti
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

Review 2.  Duchenne's muscular dystrophy: animal models used to investigate pathogenesis and develop therapeutic strategies.

Authors:  C A Collins; J E Morgan
Journal:  Int J Exp Pathol       Date:  2003-08       Impact factor: 1.925

3.  Direct interaction of beta-dystroglycan with F-actin.

Authors:  Yun-Ju Chen; Heather J Spence; Jacqueline M Cameron; Thomas Jess; Jane L Ilsley; Steven J Winder
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

Review 4.  Metabolic profiles to define the genome: can we hear the phenotypes?

Authors:  Julian L Griffin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-06-29       Impact factor: 6.237

Review 5.  Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment.

Authors:  Kristen J Nowak; Kay E Davies
Journal:  EMBO Rep       Date:  2004-09       Impact factor: 8.807

Review 6.  An open or closed case for the conformation of calponin homology domains on F-actin?

Authors:  William Lehman; Roger Craig; John Kendrick-Jones; Andrew J Sutherland-Smith
Journal:  J Muscle Res Cell Motil       Date:  2004       Impact factor: 2.698

7.  Impacts of dystrophin and utrophin domains on actin structural dynamics: implications for therapeutic design.

Authors:  Ava Yun Lin; Ewa Prochniewicz; Davin M Henderson; Bin Li; James M Ervasti; David D Thomas
Journal:  J Mol Biol       Date:  2012-04-11       Impact factor: 5.469

8.  Myosin binding protein C interaction with actin: characterization and mapping of the binding site.

Authors:  Inna N Rybakova; Marion L Greaser; Richard L Moss
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

9.  The GTPase RhoA increases utrophin expression and stability, as well as its localization at the plasma membrane.

Authors:  Armelle Bonet-Kerrache; Mathieu Fortier; Franck Comunale; Cécile Gauthier-Rouvière
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

10.  Cytoplasmic gamma-actin expression in diverse animal models of muscular dystrophy.

Authors:  Laurin M Hanft; Daniel J Bogan; Ulrike Mayer; Stephen J Kaufman; Joe N Kornegay; James M Ervasti
Journal:  Neuromuscul Disord       Date:  2007-05-01       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.